Search

everythinglearnresearchcommunity

for

Search:↓

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Immune cells affect hair growth and could lead to new hair loss treatments.

Immune cells are crucial for hair growth and preventing hair loss.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Platelets play a key role in the immune system and their lifespan and aging are important for developing new treatments.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

New insights into cell communication in psoriasis suggest innovative drug treatments.